enGene
Kelly O'Hare is an experienced quality executive with a strong background in the biotechnology and pharmaceutical industries. Currently serving as Vice President and Head of Quality at enGene, O'Hare has held senior leadership positions, including Senior Vice President of Operations and Vice President of Quality at Lykan Bioscience, as well as Vice President of Quality at Solid Biosciences and OvaScience. O'Hare's career also includes a role as Senior Director of Quality Assurance at Lantheus Medical Imaging. Kelly O'Hare holds a Bachelor of Science degree in Biomedical and Clinical Sciences from Boston University.
This person is not in any offices
enGene
enGene Inc. is a biotechnology company developing a proprietary non-viral gene therapy platform for localized delivery of nucleic acid payloads to mucosal tissues. The dually derived chitosan (DDX) platform has a high-degree of payload flexibility including DNA and various forms of RNA (siRNA, shRNA, lncRNA etc.) with broad tissue and disease applications